Early Signal Foundation Inc

Programs: Early signal has a number of programs dedicated to collect data with wearable and home sensor devices in patients with rare disorders and underserved populations. Such data is used to create analytical algorithms that can detect symptoms, track improvement or deterioration of a health condition. Such capabilities will help manage care, innovate treatment, and assess treatment efficacy. Early signal ("easi") has established collaborations with different organizations, namely, gates foundation, cohen veterans bioscience (cvb), abc2, and rettsyndrome. Org. Mother/baby health deliverygates foundation funded this project aimed at testing wearable and home sensor devices to monitor health of both mother and fetus during the prenatal period, and of mother and baby during labor and the postpartum period. A focus is to find early signs of hemorrhage, sepsis, and preeclampsia in the mother, and abnormal autonomic signs in the fetus that may warrant early testing of the neonate. Quality of life for brain cancer patients abc2 funded this project aimed at using wearable and home sensor devices to monitor health of brain cancer patients to provide feedback on subtle changes in health, ensuring peace of mind during the post-surgical period. Quantification of stereotypic behavior in rett syndromerettsyndrome. Org funded this project aimed at using wearable and home sensor devices to monitor health of girls with rett syndrome providing a quantitative index of pathology to monitor response to treatment. Objective assessment of sleep for insomniacvb funded this project and general overhead for the foundation. Objective sleep data will provide feedback to sleep coaches delivering cognitive behavioral therapy for insomnia, to ensure tailoring of treatment for the specific needs of insomnia patients suffering from ptsd and other comorbid disorders.